KIRKLAND, Wash., May 5 /PRNewswire/ -- Breakthrough biotechnology research is providing new applications for nutraceutical and functional foods in cognitive health and diabetes, two leading health concerns among consumers. Leading industry expert, Peter Leighton, CEO of Advana Science, www.advanascience.com, will present future business opportunities for the advancement of this dynamic consumer healthy category at VitaFoods International on Wednesday, May 6, 2009 at 4:55pm/16:55, Palexpo hall 1, Room K, Geneva, Switzerland.
Over the past century, nutraceuticals have filled the nutrient gap for consumer health, but the level of science and discovery has been limited. "The needs of today's consumer are multidimensional and they are seeking optimal health, not more medication," stated Leighton. "Advanced biotechnology tools that can provide greater science is now available to an industry that can deliver wellness and health quickly to the consumer."
Advana Science has found safe, natural scientific discoveries for amyloid plaque reduction that are linked to major degenerative diseases, including Alzheimer's disease and type 2 diabetes for nutraceutical application. "We are challenging the traditional paradigm of the nutraceutical industry by licensing scientifically validated natural compounds discovered with these advanced biotechnology tools."
About Advana Science
Advana Science, www.advanascience.com, is a life science company focused on developing preventative and early stage solutions for age associated memory loss and cognitive enhancement, and other conditions associated with amyloid formation such as Alzheimer's disease and Type 2 Diabetes. Advana Science oversees a broad portfolio of 42 patents that can be licensed for break-through nutraceutical products. Specific claims in these patents include memory enhancement, cognitive improvement and amyloid plaque reduction in humans.
Contact: Diana Levine 917-864-0885 email@example.com
|SOURCE Advana Science|
Copyright©2009 PR Newswire.
All rights reserved